Michel François Gilliet

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

98 publications

2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1999 | 1998 |
The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin.
Di Domizio J., Belkhodja C., Chenuet P., Fries A., Murray T., Mondéjar P.M., Demaria O., Conrad C., Homey B., Werner S. et al., 2020/09. Nature immunology, 21 (9) pp. 1034-1045. Peer-reviewed.
Baricitinib-induced paradoxical psoriasis.
Di Domizio J., Castagna J., Algros M.P., Prati C., Conrad C., Gilliet M., Wendling D., Aubin F., 2020/08. Journal of the European Academy of Dermatology and Venereology, 34 (8) pp. e391-e393. Peer-reviewed.
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus.
Lande R., Palazzo R., Gestermann N., Jandus C., Falchi M., Spadaro F., Riccieri V., James E.A., Butera A., Boirivant M. et al., 2020/04/03. Scientific reports, 10 (1) p. 5851. Peer-reviewed.
IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells.
Weiss D.I., Ma F., Merleev A.A., Maverakis E., Gilliet M., Balin S.J., Bryson B.D., Ochoa M.T., Pellegrini M., Bloom B.R. et al., 2019/08/15. Journal of immunology, 203 (4) pp. 911-921. Peer-reviewed.
Psoriasis Caught in the NET.
Di Domizio J., Gilliet M., 2019/07. The Journal of investigative dermatology, 139 (7) pp. 1426-1429. Peer-reviewed.
Autophagy links antimicrobial activity with antigen presentation in Langerhans cells.
Dang A.T., Teles R.M., Liu P.T., Choi A., Legaspi A., Sarno E.N., Ochoa M.T., Parvatiyar K., Cheng G., Gilliet M. et al., 2019/04/18. JCI insight, 4 (8). Peer-reviewed.
IL-26 contributes to host defense against intracellular bacteria.
Dang A.T., Teles R.M., Weiss D.I., Parvatiyar K., Sarno E.N., Ochoa M.T., Cheng G., Gilliet M., Bloom B.R., Modlin R.L., 2019/04/02. The Journal of clinical investigation, 129 (5) pp. 1926-1939. Peer-reviewed.
Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice.
Maul J.T., Navarini A.A., Sommer R., Anzengruber F., Sorbe C., Mrowietz U., Drach M., Blome C., Boehncke W.H., Thaci D. et al., 2019/04. Journal of the European Academy of Dermatology and Venereology, 33 (4) pp. 700-708. Peer-reviewed.
Targeted therapies and precision medicine for inflammatory skin diseases.
Gilliet M., 2019/04/01. European journal of dermatology, 29 (S1) pp. 19-24. Peer-reviewed.
Helical antimicrobial peptides assemble into protofibril scaffolds that present ordered dsDNA to TLR9.
Lee E.Y., Zhang C., Di Domizio J., Jin F., Connell W., Hung M., Malkoff N., Veksler V., Gilliet M., Ren P. et al., 2019/03/04. Nature communications, 10 (1) p. 1012. Peer-reviewed.
TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.
Kuonen F., Surbeck I., Sarin K.Y., Dontenwill M., Rüegg C., Gilliet M., Oro A.E., Gaide O., 2018/11. The Journal of investigative dermatology, 138 (11) pp. 2432-2442. Peer-reviewed.
Roger federer pourrait-il jouer en portant un large sombrero ? []
Merat R., Gilliet M., Boehncke W.H., Gaide O., 2018/08/08. Revue medicale suisse, 14 (614) pp. 1422-1423. Peer-reviewed.
Netting Neutrophils Activate Autoreactive B Cells in Lupus.
Gestermann N., Di Domizio J., Lande R., Demaria O., Frasca L., Feldmeyer L., Di Lucca J., Gilliet M., 2018/05/15. Journal of immunology, 200 (10) pp. 3364-3371. Peer-reviewed.
Innovation en dermatologie : il est temps de changer de mentalité ! []
Gilliet M., Boehncke W.H., 2018/03/28. Revue medicale suisse, 14 (600) pp. 659-660. Peer-reviewed.
Traitements systémiques émergents de la dermatite atopique [Emerging systemic treatments of atopic dermatitis]
Di Lucca-Chrisment J., Gilliet M., 2018/03/28. Revue medicale suisse, 14 (600) pp. 685-689. Peer-reviewed.
Psoriasis: from Pathogenesis to Targeted Therapies.
Conrad C., Gilliet M., 2018/02. Clinical reviews in allergy & immunology, 54 (1) pp. 102-113. Peer-reviewed.
Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment.
Riedel T., Demaria O., Zava O., Joncic A., Gilliet M., Dyson P.J., 2018/01/02. Molecular pharmaceutics, 15 (1) pp. 116-126. Peer-reviewed.
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis.
Conrad C., Di Domizio J., Mylonas A., Belkhodja C., Demaria O., Navarini A.A., Lapointe A.K., French L.E., Vernez M., Gilliet M., 2018/01/02. Nature communications, 9 (1) p. 25. Peer-reviewed.
Diversification of human plasmacytoid predendritic cells in response to a single stimulus.
Alculumbre S.G., Saint-André V., Di Domizio J., Vargas P., Sirven P., Bost P., Maurin M., Maiuri P., Wery M., Roman M.S. et al., 2018/01. Nature immunology, 19 (1) pp. 63-75. Peer-reviewed.
Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
Bujisic B., De Gassart A., Tallant R., Demaria O., Zaffalon L., Chelbi S., Gilliet M., Bertoni F., Martinon F., 2017/04/27. Blood, 129 (17) pp. 2420-2428. Peer-reviewed.
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.
Feldmeyer L., Mylonas A., Demaria O., Mennella A., Yawalkar N., Laffitte E., Hohl D., Gilliet M., Conrad C., 2017/04/01. JAMA dermatology, 153 (4) pp. 304-308. Peer-reviewed.
Choisir le bon médicament pour votre patient : evidence vs eminence-based medicine
Boehncke W.H., Gilliet M., 2017/03/29. Revue medicale suisse, 13 (556) pp. 675-676. Peer-reviewed.
Non-Melanoma Skin Cancers of the Fronto-Temporal Area Preferentially Localize in the Proximity of Arterial Blood Vessels.
Kuonen F., Gilliet M., Perrier P., 2017. Dermatology, 233 (2-3) pp. 199-204. Peer-reviewed.
Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation.
Zwicker S., Hattinger E., Bureik D., Batycka-Baran A., Schmidt A., Gerber P.A., Rothenfusser S., Gilliet M., Ruzicka T., Wolf R., 2017. PloS one, 12 (4) pp. e0175153. Peer-reviewed.
Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid.
Schaffer C., Buclin T., Jornayvaz F.R., Cazzaniga S., Borradori L., Gilliet M., Feldmeyer L., 2017. Dermatology, 233 (5) pp. 401-403. Peer-reviewed.
Xenotransplantation Model of Psoriasis.
Di Domizio J., Conrad C., Gilliet M., 2017. Methods in molecular biology, 1559 pp. 83-90. Peer-reviewed.
Colonisation of basal cell carcinoma by lentigo maligna: a case report, review of the literature, and series follow-up.
Kuonen F., Aschwanden J., Dimaio D.J., Elston D.M., Gilliet M., Hohl D., Gaide O., 2016/10/01. European journal of dermatology : EJD, 26 (5) pp. 465-469. Peer-reviewed.
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
De Gassart A., Demaria O., Panes R., Zaffalon L., Ryazanov A.G., Gilliet M., Martinon F., 2016/10. EMBO reports, 17 (10) pp. 1471-1484. Peer-reviewed.
A review of immune amplification via ligand clustering by self-assembled liquid-crystalline DNA complexes.
Lee E.Y., Lee C.K., Schmidt N.W., Jin F., Lande R., Curk T., Frenkel D., Dobnikar J., Gilliet M., Wong GCL, 2016/06. Advances in colloid and interface science, 232 pp. 17-24. Peer-reviewed.
CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.
Macal M., Tam M.A., Hesser C., Di Domizio J., Leger P., Gilliet M., Zuniga E.I., 2016. Journal of Immunology, 196 (4) pp. 1900-1909. Peer-reviewed.
Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT.
Maul J.T., Djamei V., Kolios AGA, Meier B., Czernielewski J., Jungo P., Yawalkar N., Mainetti C., Laffitte E., Spehr C. et al., 2016. Dermatology (Basel, Switzerland), 232 (6) pp. 640-647. Peer-reviewed.
PASS Syndrome: An IL-1-Driven Autoinflammatory Disease.
Leuenberger M., Berner J., Di Lucca J., Fischer L., Kaparos N., Conrad C., Hohl D., So A., Gilliet M., 2016. Dermatology (Basel, Switzerland), 232 (2) pp. 254-258. Peer-reviewed.
Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry.
Jungo P., Maul J.T., Djamei V., von Felten S., Kolios AGA, Czernielewsk J., Yawalkar N., Odermatt O., Laffitte E., Anliker M. et al., 2016. Dermatology (Basel, Switzerland), 232 (6) pp. 655-663. Peer-reviewed.
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris.
Kolios A.G., Yawalkar N., Anliker M., Boehncke W.H., Borradori L., Conrad C., Gilliet M., Häusermann P., Itin P., Laffitte E. et al., 2016. Dermatology (basel, Switzerland), 232 (4) pp. 385-406. Peer-reviewed.
Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA.
Lande R., Chamilos G., Ganguly D., Demaria O., Frasca L., Durr S., Conrad C., Schröder J., Gilliet M., 2015. European Journal of Immunology, 45 (1) pp. 203-213. Peer-reviewed.
Comparison of molecular signatures from multiple skin diseases identifies mechanisms of immunopathogenesis.
Inkeles M.S., Scumpia P.O., Swindell W.R., Lopez D., Teles R.M., Graeber T.G., Meller S., Homey B., Elder J.T., Gilliet M. et al., 2015. Journal of Investigative Dermatology, 135 (1) pp. 151-159. Peer-reviewed.
Corrigendum: the antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis.
Lande R., Botti E., Jandus C., Dojcinovic D., Fanelli G., Conrad C., Chamilos G., Feldmeyer L., Marinari B., Chon S. et al., 2015..
Liquid-crystalline ordering of antimicrobial peptide-DNA complexes controls TLR9 activation.
Schmidt N.W., Jin F., Lande R., Curk T., Xian W., Lee C., Frasca L., Frenkel D., Dobnikar J., Gilliet M. et al., 2015. Nature Materials, 14 (7) pp. 696-700. Peer-reviewed.
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O., De Gassart A., Coso S., Gestermann N., Di Domizio J., Flatz L., Gaide O., Michielin O., Hwu P., Petrova T.V. et al., 2015. Proceedings of the National Academy of Sciences of the United States of America, 112 (50) pp. 15408-15413.
SYNTHETIC BIOLOGY. Designer cells finely tuned for therapy.
Di Domizio J., Gilliet M., 2015. Science (new York, N.y.), 350 (6267) pp. 1478-1479. Peer-reviewed.
TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.
Meller S., Di Domizio J., Voo K.S., Friedrich H.C., Chamilos G., Ganguly D., Conrad C., Gregorio J., Le Roy D., Roger T. et al., 2015. Nature Immunology, 16 (9) pp. 970-979. Peer-reviewed.
Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation.
Roychoudhuri R., Lefebvre F., Honda M., Pan L., Ji Y., Klebanoff C.A., Nichols C.N., Fourati S., Hegazy A.N., Goulet J.P. et al., 2015. Vaccine, 33 (7) pp. 914-923. Peer-reviewed.
A new alternative method for testing skin irritation using a human skin model: a pilot study
Miles Alexandra, Berthet Aurélie, Hopf Nancy B., Gilliet Michel, Raffoul Wassim, Vernez David, Spring Philipp, 2014/03. Toxicology in Vitro, 28 (2) pp. 240-247. Peer-reviewed.
Immune sensing of nucleic acids in inflammatory skin diseases.
Demaria O., Di Domizio J., Gilliet M., 2014. Seminars In Immunopathology, 36 (5) pp. 519-529. Peer-reviewed.
Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy
Orcurto A., Gay B.E., Sozzi W.J., Gilliet M., Leyvraz S., 2014. Case Reports In Dermatology, 6 (1) pp. 80-84. Peer-reviewed.
Plasmacytoid dendritic cells in melanoma: can we revert bad into good?
Di Domizio J., Demaria O., Gilliet M., 2014. Journal of Investigative Dermatology, 134 (7) pp. 1797-1800. Peer-reviewed.
Prurigo nodularis: retrospective study of 13 cases managed with methotrexate.
Spring P., Gschwind I., Gilliet M., 2014. Clinical and Experimental Dermatology, 39 (4) pp. 468-473. Peer-reviewed.
Purpura of the face and neck: an atypical clinical presentation revealing a hepatosplenic T cell lymphoma
Kuonen F., Bucher M., de Leval L., Vernez M., Gilliet M., Conrad C., Feldmeyer L., 2014. Case Reports in Dermatology, 6 (1) pp. 37-42. Peer-reviewed.
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis.
Lande R., Botti E., Jandus C., Dojcinovic D., Fanelli G., Conrad C., Chamilos G., Feldmeyer L., Marinari B., Chon S. et al., 2014. Nature Communications, 5 p. 5621. Peer-reviewed.
Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison.
Conrad C., Gilliet M., 2013/05. OncoImmunology, 2 (5) pp. e23887.
Anti-TNF Therapy in the Treatment of Psoriasis in a Patient with Acute-on-Chronic Pancreatitis.
Clayton H., Flatz L., Vollenweider-Roten S., Schoepfer A., Gilliet M., Conrad C., 2013. Dermatology, 227 (3) pp. 193-196.
Two Cases of Interferon-Alpha-Induced Sarcoidosis Koebnerized along Venous Drainage Lines: New Pathogenic Insights and Review of the Literature of Interferon-Induced Sarcoidosis.
Buss G., Cattin V., Spring P., Malinverni R., Gilliet M., 2013. Dermatology, 226 (4) pp. 289-297.
Zur Krankheitslast von Psoriasis-Patienten in der Schweiz
Kolios A.G.A., Czernielewski J., Häusermann P., Yawalkar N., Navarini A.A., Thurneysen S., Laffitte E., Djamei V., Spehr C., Anliker M. et al., 2013. Dermatologica Helvetica, 25 (10) pp. 28-31.
Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37.
Chamilos G., Gregorio J., Meller S., Lande R., Kontoyiannis D.P., Modlin R.L., Gilliet M., 2012. Blood, 120 (18) pp. 3699-3707. Peer-reviewed.
Les diverses facettes de la dermatologie [The diverse areas of dermatology].
Prins C., Gilliet M., 2012. Revue Médicale Suisse, 8 (335) pp. 715-716.
Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity.
Di Domizio J., Dorta-Estremera S., Gagea M., Ganguly D., Meller S., Li P., Zhao B., Tan F.K., Bi L., Gilliet M. et al., 2012. Proceedings of the National Academy of Sciences of the United States of America, 109 (36) pp. 14550-14555.
Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.
Conrad C., Gregorio J., Wang Y.H., Ito T., Meller S., Hanabuchi S., Anderson S., Atkinson N., Ramirez P.T., Liu Y.J. et al., 2012. Cancer Research, 72 (20) pp. 5240-5249.
Type I IFNs at the interface between cutaneous immunity and epidermal remodeling.
Conrad C., Gilliet M., 2012. Journal of Investigative Dermatology, 132 (7) pp. 1759-1762.
De la pathogenèse au traitement: une nouvelle ère pour la dermatologie [From pathogenesis to treatment: a new era for dermatology].
Gilliet M., Prins C., 2011. Revue Médicale Suisse, 7 (289) pp. 731-732.
Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus.
Lande R., Ganguly D., Facchinetti V., Frasca L., Conrad C., Gregorio J., Meller S., Chamilos G., Sebasigari R., Riccieri V. et al., 2011. Science Translational Medicine, 3 (73) pp. 73ra19.
Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?
Reizis B., Colonna M., Trinchieri G., Barrat F., Gilliet M., 2011. Nature Reviews. Immunology, 11 (8) pp. 558-565.
Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses.
Chamilos G., Ganguly D., Lande R., Gregorio J., Meller S., Goldman W.E., Gilliet M., Kontoyiannis D.P., 2010. Plos One, 5 (9) pp. e12955.
Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons.
Gregorio J., Meller S., Conrad C., Di Nardo A., Homey B., Lauerma A., Arai N., Gallo R.L., Digiovanni J., Gilliet M., 2010. Journal of Experimental Medicine, 207 (13) pp. 2921-2930.
Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses.
Lande R., Gilliet M., 2010. Annals of the New York Academy of Sciences, 1183 pp. 89-103.
Chemokines in the pathogenesis of lichenoid tissue reactions.
Meller S., Gilliet M., Homey B., 2009. Journal of Investigative Dermatology, 129 (2) pp. 315-319.
Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids.
Conrad C., Meller S., Gilliet M., 2009. Seminars in Immunology, 21 (3) pp. 101-109.
Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.
Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., Homey B., Barrat F.J., Zal T., Gilliet M., 2009. Journal of Experimental Medicine, 206 (9) pp. 1983-1994.
Antimicrobial peptides and self-DNA in autoimmune skin inflammation.
Gilliet M., Lande R., 2008. Current Opinion in Immunology, 20 (4) pp. 401-407.
Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis.
Chamilos G., Lewis R.E., Hu J., Xiao L., Zal T., Gilliet M., Halder G., Kontoyiannis D.P., 2008. Proceedings of the National Academy of Sciences of the United States of America, 105 (27) pp. 9367-9372.
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.
Gilliet M., Cao W., Liu Y.J., 2008. Nature Reviews. Immunology, 8 (8) pp. 594-606.
Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.
Ito T., Hanabuchi S., Wang Y.H., Park W.R., Arima K., Bover L., Qin F.X., Gilliet M., Liu Y.J., 2008. Immunity, 28 (6) pp. 870-880.
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.
Ito T., Yang M., Wang Y.H., Lande R., Gregorio J., Perng O.A., Qin X.F., Liu Y.J., Gilliet M., 2007. Journal of Experimental Medicine, 204 (1) pp. 105-115.
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.
Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., Cao W., Wang Y.H., Su B., Nestle F.O. et al., 2007. Nature, 449 (7162) pp. 564-569.
The pathogenic role of tissue-resident immune cells in psoriasis.
Boyman O., Conrad C., Tonel G., Gilliet M., Nestle F.O., 2007. Trends in Immunology, 28 (2) pp. 51-57. Peer-reviewed.
Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma.
Cozzio A., Kempf W., Schmid-Meyer R., Gilliet M., Michaelis S., Schärer L., Burg G., Dummer R., 2006. Leukemia and Lymphoma, 47 (5) pp. 865-869.
Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.
Wang Y.H., Ito T., Wang Y.H., Homey B., Watanabe N., Martin R., Barnes C.J., McIntyre B.W., Gilliet M., Kumar R. et al., 2006. Immunity, 24 (6) pp. 827-838.
OX40 ligand shuts down IL-10-producing regulatory T cells.
Ito T., Wang Y.H., Duramad O., Hanabuchi S., Perng O.A., Gilliet M., Qin F.X., Liu Y.J., 2006. Proceedings of the National Academy of Sciences of the United States of America, 103 (35) pp. 13138-13143.
Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha.
Nestle F.O., Gilliet M., 2005. Journal of Investigative Dermatology, 125 (5) pp. xiv-xxv.
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Urosevic M., Dummer R., Conrad C., Beyeler M., Laine E., Burg G., Gilliet M., 2005. Journal of the National Cancer Institute, 97 (15) pp. 1143-1153.
Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., Burg G., Liu Y.J., Gilliet M., 2005. Journal of Experimental Medicine, 202 (1) pp. 135-143.
Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis.
Gilliet M., Cozzio A., Burg G., Nestle F.O., 2005. British Journal of Dermatology, 152 (3) pp. 531-536.
Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.
Meller S., Winterberg F., Gilliet M., Müller A., Lauceviciute I., Rieker J., Neumann N.J., Kubitza R., Gombert M., Bünemann E. et al., 2005. Arthritis and Rheumatism, 52 (5) pp. 1504-1516.
Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
Cozzio A., Hafner J., Kempf W., Häffner A., Palmedo G., Michaelis S., Gilliet M., Zimmermann D., Burg G., 2004. Journal of the American Academy of Dermatology, 51 (6) pp. 1014-1017.
Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL-15.
Castelli J., Thomas E.K., Gilliet M., Liu Y.J., Levy J.A., 2004. Blood, 103 (7) pp. 2699-2704.
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
Gilliet M., Conrad C., Geiges M., Cozzio A., Thürlimann W., Burg G., Nestle F.O., Dummer R., 2004. Archives of Dermatology, 140 (12) pp. 1490-1495.
Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity.
Fonteneau J.F., Gilliet M., Larsson M., Dasilva I., Münz C., Liu Y.J., Bhardwaj N., 2003. Blood, 101 (9) pp. 3520-3526.
Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation.
Boonstra A., Asselin-Paturel C., Gilliet M., Crain C., Trinchieri G., Liu Y.J., O'Garra A., 2003. Journal of Experimental Medicine, 197 (1) pp. 101-109.
Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
Kleinhans M., Tun-Kyi A., Gilliet M., Kadin M.E., Dummer R., Burg G., Nestle F.O., 2003. Blood, 101 (4) pp. 1487-1493.
Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells.
Gilliet M., Soumelis V., Watanabe N., Hanabuchi S., Antonenko S., de Waal-Malefyt R., Liu Y.J., 2003. Journal of Experimental Medicine, 197 (8) pp. 1059-1063.
Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen.
Gilliet M., Kleinhans M., Lantelme E., Schadendorf D., Burg G., Nestle F.O., 2003. Blood, 102 (1) pp. 36-42.
Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.
Gilliet M., Liu Y.J., 2002. Journal of Experimental Medicine, 195 (6) pp. 695-704.
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.
Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A. et al., 2002. Nature Immunology, 3 (7) pp. 673-680.
Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells.
Gilliet M., Liu Y.J., 2002. Human Immunology, 63 (12) pp. 1149-1155.
The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor.
Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., O'Garra A., Liu Y.J., 2002. Journal of Experimental Medicine, 195 (7) pp. 953-958.
Dendritic cell lineage, plasticity and cross-regulation.
Liu Y.J., Kanzler H., Soumelis V., Gilliet M., 2001. Nature Immunology, 2 (7) pp. 585-589.
Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation.
Macagno A., Gilliet M., Sallusto F., Lanzavecchia A., Nestle F.O., Groettrup M., 1999. European Journal of Immunology, 29 (12) pp. 4037-4042.
Vakzinationstherapie des malignen Melanoms [Vaccination therapy of malignant melanoma].
Nestle F.O., Tun Kyi A., Gilliet M., Dummer R., Burg G., 1999. Therapeutische Umschau. Revue Thérapeutique, 56 (6) pp. 334-337.
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.
Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D., 1998. Nature Medicine, 4 (3) pp. 328-332.
Unicentre - CH-1015 Lausanne
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University